Monoclonal antibodies are essential tools for many molecular immunology investigations. In
particular, when used in combination with techniques such as epitope mapping and …

The end of twentieth century has introduced some changes into T helper (Th) cells division.
The identification of the new subpopulation of T helper cells producing IL-17 modified model …

We propose filtering historical simulation by GARCH processes to model the future
distribution of assets and swap values. Options' price changes are computed by full …

Today, the classification systems for myelodysplastic syndromes (MDS) and acute myeloid
leukemia (AML) already incorporate cytogenetic and molecular genetic aberrations in an …

Antigen targeted immunotherapies might represent a novel treatment for B-cell chronic
lymphocytic leukemia (B-CLL). We screened the mRNA expression of tumor-associated …

The receptor for hyaluronic acid-mediated motility (RHAMM) is a tumor-associated antigen
in chronic lymphocytic leukemia (CLL). CD8+ T cells primed with the RHAMM-derived …

Background Zanubrutinib is a next-generation, selective Bruton tyrosine kinase inhibitor with
efficacy in relapsed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma …

The expression of tumor-associated antigens (TAAs) might play a critical role in the control
of minimal residual disease (MRD) in acute myeloid leukemia (AML), and therefore might be …

Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients
with (quasi) identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …

The receptor for hyaluronic acid–mediated motility (RHAMM) is an antigen eliciting both
humoral and cellular immune responses in patients with acute myeloid leukemia (AML) …